Experienced in Necrosis

Dr. John D. Gabriel

Family Medicine
Baylor Scott & White Health
North Hills Family Medicine
4351 Booth Calloway Rd Ste 101, North, 
North Richland Hills, TX 
Offers Telehealth
48 Years of Experience

Experienced in Necrosis
Baylor Scott & White Health
North Hills Family Medicine
4351 Booth Calloway Rd Ste 101, North, 
North Richland Hills, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

John Gabriel is a primary care provider, practicing in Family Medicine in North Richland Hills, Texas. Dr. Gabriel has been practicing medicine for over 48 years and is rated as an Experienced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Sinusitis, Empyema, Avian Influenza, and Type 2 Diabetes (T2D).

His clinical research consists of participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Texas Southwestern Medical School, 1978.0
Residency
Family Medicine, St Paul Medical Center TX
Specialties
Family Medicine
Licenses
Family Medicine in TX
Board Certifications
American Board Of Family Medicine
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Cook Children's Health Plan
  • MANAGED MEDICAID PLAN
EMI Health
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Nippon Life
  • INSURANCE PLAN
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Scott and White Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 29 Less Insurance Carriers -

Locations

North Hills Family Medicine
4351 Booth Calloway Rd Ste 101, North, North Richland Hills, TX 76180
Call: 214-666-8077

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes
A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Drug
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
Enrollment Status: Completed
Publish Date: May 22, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Lispro, Insulin Glargine
Study Phase: Phase 3
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo and Dulaglutide in Participants With Type 2 Diabetes
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo and Dulaglutide in Participants With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Drugs: LY3437943, Dulaglutide
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab, LY3853113 Anti-COVID-19 Antibody, VIR-7831 Anti-COVID-19 Antibody
Study Phase: Phase 2
View 6 Less Clinical Trials
Similar Doctors
Distinguished in Necrosis
Dr. Andrew J. Applewhite
Family Medicine
Distinguished in Necrosis
Dr. Andrew J. Applewhite
Family Medicine

A. J. Applewhite, MD, PA

3500 Gaston Avenue Barnett Tower, Suite 210, 
Dallas, TX 
 (26.5 miles away)
972-449-0540
Experience:
30+ years
Languages Spoken:
English
See accepted insurances

Andrew Applewhite is a primary care provider, practicing in Family Medicine in Dallas, Texas. Dr. Applewhite has been practicing medicine for over 30 years and is rated as a Distinguished provider by MediFind in the treatment of Necrosis. His top areas of expertise are Peptic Ulcer, Necrosis, Cellulitis, and Stasis Dermatitis and Ulcers.

Distinguished in Necrosis
Dr. Stephanie B. Newsom
Family Medicine | Emergency Medicine | General Surgery
Distinguished in Necrosis
Dr. Stephanie B. Newsom
Family Medicine | Emergency Medicine | General Surgery

Vohra Post Acute Care Physicians Of Texas, PLLC

3325 W Plano Pkwy, 
Plano, TX 
 (29.7 miles away)
877-866-7123
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Stephanie Newsom is an Emergency Medicine specialist and a General Surgeon in Plano, Texas. Dr. Newsom is rated as a Distinguished provider by MediFind in the treatment of Necrosis. Her top areas of expertise are Necrosis, Peptic Ulcer, Cellulitis, and Nakajo-Nishimura Syndrome. Dr. Newsom is currently accepting new patients.

Distinguished in Necrosis
Dr. Shanti Velagapudi
Family Medicine
Distinguished in Necrosis
Dr. Shanti Velagapudi
Family Medicine

Vohra Post Acute Care Physicians Of Texas, PLLC

17218 Preston Rd, Suite 2000, 
Dallas, TX 
 (26.5 miles away)
469-518-8472
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Shanti Velagapudi is a primary care provider, practicing in Family Medicine in Dallas, Texas. Dr. Velagapudi is rated as a Distinguished provider by MediFind in the treatment of Necrosis. Her top areas of expertise are Peptic Ulcer, Necrosis, Cellulitis, and Hereditary Mucoepithelial Dysplasia. Dr. Velagapudi is currently accepting new patients.

VIEW MORE NECROSIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gabriel's expertise for a condition
ConditionClose
      • Advanced
      • Avian Influenza
        Dr. Gabriel is
        Advanced
        . Learn about Avian Influenza.
        See more Avian Influenza experts
      • Empyema
        Dr. Gabriel is
        Advanced
        . Learn about Empyema.
        See more Empyema experts
      • Sinusitis
        Dr. Gabriel is
        Advanced
        . Learn about Sinusitis.
        See more Sinusitis experts
      • Type 2 Diabetes (T2D)
        Dr. Gabriel is
        Advanced
        . Learn about Type 2 Diabetes (T2D).
        See more Type 2 Diabetes (T2D) experts
      • Experienced
      • Allergic Rhinitis
        Dr. Gabriel is
        Experienced
        . Learn about Allergic Rhinitis.
        See more Allergic Rhinitis experts
      • Aphthous Stomatitis
        Dr. Gabriel is
        Experienced
        . Learn about Aphthous Stomatitis.
        See more Aphthous Stomatitis experts
      • Apoplexy
        Dr. Gabriel is
        Experienced
        . Learn about Apoplexy.
        See more Apoplexy experts
      • Asperger's Syndrome
        Dr. Gabriel is
        Experienced
        . Learn about Asperger's Syndrome.
        See more Asperger's Syndrome experts
      • Asthma
        Dr. Gabriel is
        Experienced
        . Learn about Asthma.
        See more Asthma experts
      • Attention Deficit Hyperactivity Disorder (ADHD)
        Dr. Gabriel is
        Experienced
        . Learn about Attention Deficit Hyperactivity Disorder (ADHD).
        See more Attention Deficit Hyperactivity Disorder (ADHD) experts
      View All 82 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

          Close
          0 / 1000

          Please provide us with the below insurance information:

                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.